Apellis Pharmaceuticals, Inc. (APLS)
USD 18.37
(1.13%)
USD 18.37
(1.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -594.73 Million | -513.74 Million | -563.12 Million | -160.48 Million | -211.13 Million | -131.24 Million |
| Net Income | -528.62 Million | -652.17 Million | -746.35 Million | -344.87 Million | -304.7 Million | -127.5 Million |
| Depreciation & Amortization | 1.7 Million | 1.48 Million | 1.49 Million | 637 Thousand | 239.68 Thousand | - |
| Deferred income taxes | -368.54 Million | - | 198.26 Million | 103.02 Million | 16.34 Million | - |
| Stock-based compensation | 105.94 Million | 91.08 Million | 70.66 Million | 45.37 Million | 21.14 Million | 7.73 Million |
| Change in working capital | -200.16 Million | -15.69 Million | -93.52 Million | 19.58 Million | 53.14 Million | -12.04 Million |
| Other non-cash items | 394.95 Million | 61.55 Million | 6.32 Million | 15.75 Million | 2.69 Million | 568.32 Thousand |
| Investing Cash Flow | -674 Thousand | 59.89 Million | 247.61 Million | -316.98 Million | -1.69 Million | - |
| Investments in PPE | -773 Thousand | -1.52 Million | -1.1 Million | -5.42 Million | -1.69 Million | - |
| Acquisitions | 99 Thousand | -61.41 Million | -248.71 Million | 311.56 Million | - | - |
| Investment purchases | - | -331.86 Million | -171.28 Million | -879.06 Million | - | - |
| Sales/Maturities of investments | - | 393.28 Million | 420 Million | 567.5 Million | - | - |
| Other Investing Activities | 99 Thousand | 61.41 Million | 248.71 Million | -311.56 Million | - | - |
| Financing Cash Flow | 394.49 Million | 365.65 Million | 392.23 Million | 692.17 Million | 388.54 Million | 131.9 Million |
| Debt repayment | - | - | - | -322.87 Million | -28.7 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -11.04 Million | 4.23 Million | -1.78 Million | 1.57 Million | - | - |
| Common Stock Issuance | 461.03 Million | 380.12 Million | 398.02 Million | 381.42 Million | 109.58 Million | 131.19 Million |
| Other Financing Activities | 405.53 Million | -18.69 Million | 394.02 Million | 954.92 Million | 307.66 Million | 709.33 Thousand |
| Accounts receivables | -198.71 Million | 2.37 Million | -10.1 Million | - | - | - |
| Accounts payables | 170 Thousand | 18.68 Million | 10.48 Million | -54 Thousand | -1.64 Million | 6.58 Million |
| Inventory | -60.64 Million | -69.39 Million | -16.31 Million | - | - | - |
| Other working capital | 59.02 Million | 32.63 Million | -77.58 Million | 19.64 Million | 54.79 Million | -18.62 Million |
| Cash at beginning of period | 553.07 Million | 641.75 Million | 567.04 Million | 351.98 Million | 176.26 Million | 175.64 Million |
| Cash at end of period | 352.29 Million | 553.07 Million | 641.75 Million | 567.04 Million | 351.98 Million | 176.26 Million |
| Capital Expenditure | -773 Thousand | -1.52 Million | -1.1 Million | -5.42 Million | -1.69 Million | - |
| Effect of forex changes on cash | 135 Thousand | -488 Thousand | -2.01 Million | 359 Thousand | 4702.00 | -38.42 Thousand |
| Net cash flow / Change in cash | -200.77 Million | -88.68 Million | 74.71 Million | 215.06 Million | 175.71 Million | 624.13 Thousand |
| Free Cash Flow | -595.5 Million | -515.26 Million | -564.22 Million | -165.91 Million | -212.82 Million | -131.24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -57.44 Million | -37.65 Million | -66.42 Million | -88.57 Million | -528.62 Million | -140.23 Million |
| Depreciation & Amortization | 457 Thousand | 449 Thousand | 444 Thousand | 490 Thousand | 1.7 Million | 405 Thousand |
| Deferred income taxes | - | - | - | -133 Thousand | -368.54 Million | 133 Thousand |
| Stock-based compensation | 27.47 Million | 29.99 Million | 30.34 Million | 26.21 Million | 105.94 Million | 21.62 Million |
| Change in working capital | 109.67 Million | -6.17 Million | -103.49 Million | -42.55 Million | -200.16 Million | -57.49 Million |
| Other non-cash items | -46.06 Million | 75.54 Million | 124.44 Million | 6.68 Million | 394.95 Million | 6.48 Million |
| Investing Cash Flow | - | -90 Thousand | -293 Thousand | 4000.00 | -674 Thousand | -47 Thousand |
| Investments in PPE | - | -90 Thousand | -293 Thousand | -95 Thousand | -773 Thousand | -47 Thousand |
| Acquisitions | - | - | - | 99 Thousand | 99 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 99 Thousand | 99 Thousand | - |
| Financing Cash Flow | 2.54 Million | 42.48 Million | 108.21 Million | -3.91 Million | 394.49 Million | 5.74 Million |
| Debt repayment | -136.09 Million | -37.33 Million | -98.76 Million | -24.5 Million | - | - |
| Dividends payments | - | - | - | -1.56 Million | - | - |
| Common Stock Repurchased | 3.22 Million | - | -28 Thousand | -2000.00 | -11.04 Million | -11 Thousand |
| Common Stock Issuance | -14.63 Million | 5.15 Million | 9.47 Million | 27.08 Million | 461.03 Million | 5.75 Million |
| Other Financing Activities | 150.04 Million | -229.35 Million | -28 Thousand | -3.91 Million | 405.53 Million | 5.75 Million |
| Accounts receivables | 25.42 Million | -36.57 Million | -61.41 Million | -37.17 Million | -198.71 Million | -58.35 Million |
| Accounts payables | -1.15 Million | 11.48 Million | -10.73 Million | 19.62 Million | 170 Thousand | -9.6 Million |
| Inventory | 8.65 Million | -14.51 Million | -14.92 Million | -47.81 Million | -60.64 Million | 4.67 Million |
| Other working capital | -16.98 Million | 33.41 Million | -16.42 Million | 22.81 Million | 59.02 Million | 5.78 Million |
| Cash at beginning of period | 361.42 Million | 327.02 Million | 352.29 Million | 453.5 Million | 553.07 Million | 617.34 Million |
| Cash at end of period | 398.23 Million | 361.42 Million | 327.02 Million | 352.29 Million | 352.29 Million | 453.5 Million |
| Capital Expenditure | - | -90 Thousand | -293 Thousand | -95 Thousand | -773 Thousand | -47 Thousand |
| Effect of forex changes on cash | 173 Thousand | 342 Thousand | -209 Thousand | 584 Thousand | 135 Thousand | -458 Thousand |
| Net cash flow / Change in cash | 36.81 Million | 34.4 Million | -25.27 Million | -101.2 Million | -200.77 Million | -163.84 Million |
| Free Cash Flow | 34.09 Million | -8.42 Million | -133.27 Million | -97.97 Million | -595.5 Million | -169.13 Million |
ABO
4634
SNM
VTWRF
QD
9213